Founded
31 Dec 2007
Address
Akebia Therapeutics Inc
9987 Carver Road
Suite 420
Cincinnati, OH 45242
United States
Phone
Website
Business classification
VCID: 130698
Profile
Corporate information
Official name
Akebia Therapeutics Incorporated
Registration country
Official name
Akebia Therapeutics Incorporated
Registration country
Investment activity status
Active investor
Funding
Funding rounds
(1 Apr 2011)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Athenian Venture Partners | Venture capital firm specializing in early stage investments in information technology, healthcare and digital health. | United States | ||
Kearny Venture Partners | United States | |||
Novartis Venture Funds | The corporate venturing arm of Novartis. | Switzerland | ||
Sigvion Capital | United States | |||
Triathlon Medical Ventures LLC | United States | |||
Venture Investors LLC | United States |
(1 Sep 2009)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Athenian Venture Partners | Venture capital firm specializing in early stage investments in information technology, healthcare and digital health. | United States | ||
Novartis Venture Funds | The corporate venturing arm of Novartis. | Switzerland | ||
Sigvion Capital | United States | |||
Technology Venture Investors | United States | |||
Triathlon Medical Ventures LLC | United States |
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Blue Chip Venture Co | United States | |||
Novartis Services Inc | United States | |||
Venture Investors LLC | United States |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Athenian Venture Partners Venture capital firm specializing in early stage investments in information technology, healthcare and digital health. |
+1 (954) 315-2091 |
Series A Series B |
|
Blue Chip Venture Co |
+1 (317) 275-6800 |
N/A | |
Kearny Venture Partners |
+1 (415) 364-5999 |
Series B | |
Novartis Services Inc |
+1 (617) 871-3536 |
N/A | |
Novartis Venture Funds The corporate venturing arm of Novartis. |
+41 (61) 324-6210 |
Series A Series B |
|
Sigvion Capital |
+1 (312) 226-6373 |
Series A Series B |
|
Technology Venture Investors |
Series A | ||
Triathlon Medical Ventures LLC |
Series A Series B |
||
Venture Investors LLC |
+1 (734) 274-2904 |
N/A Series B |